AMBARELLA INC (AMBA)

KYG037AX1015 - Common Stock

71.55  -0.89 (-1.23%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMBA. AMBA was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. While AMBA has a great health rating, there are worries on its profitability. While showing a medium growth rate, AMBA is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

AMBA had negative earnings in the past year.
In the past year AMBA had a positive cash flow from operations.
AMBA had negative earnings in each of the past 5 years.
Each year in the past 5 years AMBA had a positive operating cash flow.

1.2 Ratios

AMBA has a Return On Assets of -26.93%. This is amonst the worse of the industry: AMBA underperforms 82.41% of its industry peers.
AMBA has a worse Return On Equity (-31.99%) than 78.70% of its industry peers.
Industry RankSector Rank
ROA -26.93%
ROE -31.99%
ROIC N/A
ROA(3y)-12.99%
ROA(5y)-11.58%
ROE(3y)-15.29%
ROE(5y)-13.69%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMBA's Gross Margin of 60.22% is amongst the best of the industry. AMBA outperforms 83.33% of its industry peers.
AMBA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AMBA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.22%
GM growth 5Y-0.07%

7

2. Health

2.1 Basic Checks

AMBA does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMBA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMBA has more shares outstanding
There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 16.90 indicates that AMBA is not in any danger for bankruptcy at the moment.
AMBA's Altman-Z score of 16.90 is amongst the best of the industry. AMBA outperforms 87.04% of its industry peers.
There is no outstanding debt for AMBA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.9
ROIC/WACCN/A
WACC14.73%

2.3 Liquidity

A Current Ratio of 3.06 indicates that AMBA has no problem at all paying its short term obligations.
AMBA's Current ratio of 3.06 is in line compared to the rest of the industry. AMBA outperforms 52.78% of its industry peers.
A Quick Ratio of 2.72 indicates that AMBA has no problem at all paying its short term obligations.
AMBA has a Quick ratio (2.72) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 2.72

4

3. Growth

3.1 Past

The earnings per share for AMBA have decreased strongly by -48.57% in the last year.
Looking at the last year, AMBA shows a very negative growth in Revenue. The Revenue has decreased by -32.92% in the last year.
Measured over the past years, AMBA shows a decrease in Revenue. The Revenue has been decreasing by -0.12% on average per year.
EPS 1Y (TTM)-48.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%139.29%
Revenue 1Y (TTM)-32.92%
Revenue growth 3Y0.52%
Revenue growth 5Y-0.12%
Sales Q2Q%63.36%

3.2 Future

Based on estimates for the next years, AMBA will show a very strong growth in Earnings Per Share. The EPS will grow by 42.70% on average per year.
The Revenue is expected to grow by 26.03% on average over the next years. This is a very strong growth
EPS Next Y38.77%
EPS Next 2Y33.04%
EPS Next 3Y43.28%
EPS Next 5Y42.71%
Revenue Next Year16.13%
Revenue Next 2Y17.68%
Revenue Next 3Y20.88%
Revenue Next 5Y26.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMBA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMBA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as AMBA's earnings are expected to grow with 43.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.04%
EPS Next 3Y43.28%

0

5. Dividend

5.1 Amount

No dividends for AMBA!.
Industry RankSector Rank
Dividend Yield N/A

AMBARELLA INC

NASDAQ:AMBA (11/29/2024, 12:36:03 PM)

71.55

-0.89 (-1.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.95B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.93%
ROE -31.99%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 60.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.06
Quick Ratio 2.72
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-48.57%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y38.77%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-32.92%
Revenue growth 3Y0.52%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y